CBD (Cannabidiol) Transactions and Operation

Dedicated guide for merchants selling cannabidiol (CBD) products to Brazilian patients WEpayments is specialized in supporting platforms and distributors that commercialize cannabidiol (CBD) medicinal products. We act as strategic partners in payment processing and FX operations, with a focus on transparency, compliance, and operational efficiency.

ANVISA regulatory framework

The sale of CBD medications in Brazil follows ANVISA RDC nº 660/2020 guidelines.

Patient journey requirements

Step	Description
1. Medical prescription	Issued by a qualified healthcare professional
2. ANVISA authorization	Patient (or legal guardian) registers with ANVISA, attaching the prescription
3. Authorized purchase	With authorization, the patient can purchase medication through your platform

Recommended operational structure with WEpayments

Foreign company

Requirement	Description
Role	Legal seller of the medication, generates charge to patient
Account	Must have an active cross-border account at WEpayments
Responsibility	Responsible for the sale and payment processing

Brazilian company

Requirement	Description
Role	Service provider representing the foreign company’s products in Brazil
Restriction	No corporate overlap between foreign and Brazilian company
Compensation	Paid by foreign company via WEpayments Payout for representation or support services

⚠️ Critical: There must be no shared corporate structure between the foreign seller and the Brazilian representative.

Payment processing

Transaction model

Aspect	Details
Model	Simultaneous exchange (eFX) – BCB Resolution nº 277/2022
Currency	Charges in Brazilian reais (BRL)
Reporting	Payin (incoming) and Payout (outgoing) in the system
Release condition	Funds only released after document validation

Payment methods

Method	Processing
PIX	Works normally, funds held until document approval
Boleto	Works normally, funds held until document approval
Credit Card	Works normally, funds held until document approval

Required documentation

For the payment to be released and correctly classified as an international CBD transaction, the following documents must be submitted by the patient via your platform:

Document	Source	Required for release
Medical prescription	Patient	✅ Yes
ANVISA authorization	Patient	✅ Yes
Invoice	Your platform	✅ Yes
Identity document	Patient or legal guardian	✅ Yes

Payment and release timeline

Status behavior

Step	Status in Dashboard	Funds available?
Payment created (PIX/Cards)	“Created”	❌ No
Payment executed (PIX/boleto)	“Paid”	❌ No
Payment executed (Credit Card)	“Paid”	❌ No
Documents submitted	”Awaiting analysis”	❌ No
Documents approved	”Credited”	✅ Yes

Analysis schedule

Aspect	Details
Analysis days	Business days only
Analysis cut-off	Until 12:00 BRT
Status monitoring	WEpayments Dashboard > Compliance menu

Benefits of the eFX model for CBD

Benefit	Description
Agility	Faster payment processing
FX exposure	Reduced exposure to currency fluctuation
Compliance	100% aligned with Brazilian regulations (ANVISA + BCB)
Local settlement	International operation with funds maintained in Brazil

Getting started with CBD operations

Step	Action
1. Contact WEpayments	Speak with our team to activate your account
2. Configure limits	Set appropriate limits for your operation
3. Integrate	Use our API or Dashboard to start processing
4. Collect documents	Implement document collection in your patient flow
5. Monitor compliance	Track status in the Compliance menu

​ANVISA regulatory framework

​Patient journey requirements

​Recommended operational structure with WEpayments

​Foreign company

​Brazilian company

​Payment processing

​Transaction model

​Payment methods

​Required documentation

​Payment and release timeline

​Status behavior

​Analysis schedule

​Benefits of the eFX model for CBD

​Getting started with CBD operations